Home Nucleus Pharmaceuticals Italy Influenza Drug Market to 2032

Italy Influenza Drug Market to 2032

Overview

The Italy Influenza Drug Market is expected to reach a 339.33 USD Million by 2032 and is projected to grow at a CAGR of 6.94% from 2025 to 2032.

Revenue, 2024 (USD Million)
220.18
Forecast, 2032 (USD Million)
339.33
CAGR, 2024 - 2032
6.94%
Report Coverage
Italy

Italy Influenza Drug Market 2018-2032 USD Million

Italy Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 220.18 USD Million
  • Projected Market Size (2032): 339.33 USD Million
  • CAGR (2025-2032): 6.94%

Key Findings of Italy Influenza Drug Market

  • The Italy Influenza Drug Market was valued at 220.18 USD Million in 2024.
  • The Italy Influenza Drug Market is likely to grow at a CAGR of 6.94% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 384.82 USD Million
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.67% during the forecast period from 2024 to 2032.

Italy Influenza Drug Market Scope

Italy Influenza Drug Market Segmentation & Scope
Treatment
  • Drugs
  • Vaccines
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Adults
  • Pediatrics
End User
  • Homecare
  • Hospitals
Type
  • Influenza C
  • Influenza B
  • Influenza A
Distribution Channel
  • Retail Sales
  • Direct Tender

Italy Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 220.18 USD Million
Market Value in 2032 339.33 USD Million
CAGR (2025-2032) 6.94%
Historic Data 2016-2023
Market Segments Covered Treatment,Route of Administration,Age,End User,Type,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): Italy, leading in terms of revenue 220.18 USD Million in 2024
    • Key Country: Italy, leading in terms of revenue with value of 220.18 USD Million in 2024.

Segments and Scope

  • Italy Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in Italy Influenza Drug Market to 2032 with a revenue of 384.82 USD Million in the year 2024.
    • Vaccines is the Fastest growing segment in Italy Influenza Drug Market to 2032 with a Growth rate of 6.97 % in forecast period 2025-2032.
  • Italy Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in Italy Influenza Drug Market to 2032 with a revenue of 98.92 USD Million in the year 2024.
    • Oral is the Fastest growing segment in Italy Influenza Drug Market to 2032 with a Growth rate of 7.67 % in forecast period 2025-2032.
  • Italy Influenza Drug Market to 2032, By Age
    • Pediatrics is the largest segment in Italy Influenza Drug Market to 2032 with a revenue of 113.64 USD Million in the year 2024.
    • Pediatrics is the Fastest growing segment in Italy Influenza Drug Market to 2032 with a Growth rate of 7.36 % in forecast period 2025-2032.
  • Italy Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in Italy Influenza Drug Market to 2032 with a revenue of 161.19 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in Italy Influenza Drug Market to 2032 with a Growth rate of 7.11 % in forecast period 2025-2032.
  • Italy Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in Italy Influenza Drug Market to 2032 with a revenue of 107.13 USD Million in the year 2024.
    • Influenza A is the Fastest growing segment in Italy Influenza Drug Market to 2032 with a Growth rate of 7.41 % in forecast period 2025-2032.
  • Italy Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Italy Influenza Drug Market to 2032 with a revenue of 125.48 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in Italy Influenza Drug Market to 2032 with a Growth rate of 7.25 % in forecast period 2025-2032.

Italy Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
Italy Influenza Drug Market Company Share Analysis

Italy Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Italy Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Italy Influenza Drug Market Company Profiling

Italy Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The Italy Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Type,Distribution Channel.
Italy Influenza Drug Market was valued at USD 220.18(Revenue in USD Million) in 2022.
Italy Influenza Drug Market is projected to grow at a CAGR of 6.94% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the Italy Influenza Drug Market, holding a largest market share of 384.82 USD Million in 2024

Italy Influenza Drug Market Scope

Italy Influenza Drug Market Segmentation & Scope
Treatment
  • Drugs
  • Vaccines
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Adults
  • Pediatrics
End User
  • Homecare
  • Hospitals
Type
  • Influenza C
  • Influenza B
  • Influenza A
Distribution Channel
  • Retail Sales
  • Direct Tender
Frequently Asked Questions
The Italy Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Type,Distribution Channel.
Italy Influenza Drug Market was valued at USD 220.18(Revenue in USD Million) in 2022.
Italy Influenza Drug Market is projected to grow at a CAGR of 6.94% during the forecast period of 2024 to 2032.
The estimated market value of the Italy Influenza Drug Market for final year is USD 339.33 (USD Million).

Italy Influenza Drug Market Company Profiling

Italy Influenza Drug Market Company Profiling
Frequently Asked Questions
The Italy Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Type,Distribution Channel.
Italy Influenza Drug Market was valued at USD 220.18(Revenue in USD Million) in 2022.
Italy Influenza Drug Market is projected to grow at a CAGR of 6.94% during the forecast period of 2024 to 2032.
The estimated market value of the Italy Influenza Drug Market for final year is USD 339.33 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES